CHILDHOOD CANCER REPOSITORY

Powered by

Alex's Lemonade Stand Foundation

Rhabdomyosarcoma

RequestCell LinePDXPhase of TherapyDiagnosisSample TypeAgep53pO2
        2% O25% O220%O2
Rh18-DxRhabdomyosarcoma, embryonalperineum 2N--
Rh30-DxRhabdomyosarcoma, alveolarbone marrow17F--
Rh41-PDRhabdomyosarcoma, alveolarlung tumor  --
CB-NJR--Rhabdomyosarcomaunknown   - -
CB-NJR--Rhabdomyosarcomaunknown   - -
SMS-CTR--Rhabdomyosarcoma, embryonal    - -
CHLA-33--Rhabdomyosarcomatumor   - -
CHLA-37-DxRhabdomyosarcomatumor   - -
CHLA-50--Rhabdomyosarcomatumor   - -
CHLA-186-PD-BMTRhabdomyosarcomaperitoneal fulid   - -
COG-R-262-PD-BMTRhabdomyosarcomapericardial fluid   - -
COG-R-264-PD-BMTRhabdomyosarcoma    - -
COG-R-267--Rhabdomyosarcomabrain tumor   - -
-COG-R-438xPDRhabdomyosarcomatumor  ---
COG-R-466h-PD-PMRhabdomyosarcoma, embryonaltumor (autopsy)   - -
-COG-R-668xDxRhabdomyosarcomatumor  ---

1 - Phase of therapy for the patient at the time the specimen used to derive the cell line was obtained
Dx (Diagnosis): cell lines derived from samples of patients prior to treatment
PD (Progressive Disease): cell lines derived from samples of patients who relapsed after chemotherapy
PD-BMT: cell lines derived from samples of patients who relapsed after chemotherapy and bone marrow transplantation
PD-PM: cell lines derived from samples of post-mortem patients who relapsed after chemotherapy

3 - TP53 gene function
F: Functional
N: Non-Functional

✓ = Available/available upon request

SQ- subcutaneous injection

TV- intravenous (tail vein)

EST- ever shorter telomeres, i.e. telomerase and ALT negative

TERT+- telomerase positive

ALT - alternate lengthening of telomeres, C-circle positive